A new study highlights the Cardio-Ankle Vascular Index (CAVI) as a powerful tool for predicting COPD progression and outcomes ...

and lifestyle changes Chronic obstructive pulmonary disease, commonly referred to as COPD, is a group of progressive lung diseases. An estimated 32 million people in the United States have COPD.

GSK plc (NYSE:GSK) has strengthened its market outlook following major regulatory milestones. The U.S. FDA’s recent approval ...

The U.S Food and Drug Administration has approved Nucala, British drugmaker GSK's asthma drug, to treat some patients with a ...

Approval of Nucala marks the first biologic approved for chronic obstructive pulmonary disease patients with blood eosinophil counts as low as ≥150 cells/μL.

Certain groups of physical multimorbidity may be associated with a higher risk of subsequent depression, according to a study ...

The U.S. Food and Drug Administration has approved Nucala (mepolizumab) as an add-on maintenance treatment for adult patients ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as ...

Women over 40 face a higher risk of chronic lung disease, possibly due to indoor pollution, hormonal shifts, and misdiagnosis ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

People living with multiple chronic health conditions are at a significantly greater risk of developing depression, new ...

Certain groups of physical multimorbidity may be associated with a higher risk of subsequent depression, according to a recent study.